Dr. Harvey Lee Carter III, MD

Dr. Carter practices at Carter Eye Center in Dallas, Texas.

Dr. Carter's NPI, 1164430187, was assigned on August 4, 2006. Dr. Carter graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1982. Dr. Carter holds Texas license H1564.

Dr. Carter's primary practice is Carter Eye Center, at 5315 N Central Expressway, Dallas, TX 75205-3319. The practice phone is (214) 750-1962.

Dr. Carter's primary practice is Carter Eye Center in Dallas, Texas. Dmand AI also links Dr. Carter to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carter practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Carter's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Carter is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Carter's licenses on file in 2 states: Texas and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Carter treats.

CMS data shows 1,417 Medicare services from Dr. Carter across 15 procedure codes in 2024, for 298 Medicare patients. Medicare paid $140,663 for them.

CMS counts 298 Medicare patients who saw Dr. Carter in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carter's median patient age at 73, with 49% women.

In 2024, Dr. Carter wrote 520 Medicare Part D claims for 196 patients. 46% of them were for generic drugs. CMS names the drug for 431 of them, across 7 drugs with 11 or more claims each, at $14,939 in total drug cost. In 2023, CMS named 343 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Carter for performance year 2024, reported as part of a group. Dr. Carter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 173 procedures of cataract surgery by Dr. Carter, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Carter in 2016. Dr. Carter's most frequent co-authors are John A. Hovanesian, MD, Jeffrey Whitman, MD and James A. Davies, MD.

Dmand AI links Dr. Carter to 1 clinical trial. Conditions studied include Cataract and Lens Diseases.

CMS Open Payments shows 328 general payments to Dr. Carter from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Alcon Laboratories Inc paid the most, $4,640. It also lists 2 research payments totaling $22,824 in 2016.

Dr. Carter graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1982.

Dr. Carter is in network with 18 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Massachusetts. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.